Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

PRAN 1.89 -0.04 (-1.99%)
price chart
Prana Biotechnology Limited (ADR) (PRAN) news: Prana: Right Drug, Wrong Dose
Prana Biotechnology Limited (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer's disease within the coming month.
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotechnology - A ...
One company in particular, Prana Biotechnology (NASDAQ:PRAN), is well-positioned to address this market with their lead drug, and in a realistic but optimistic scenario, the share price could ducuple (increase by 10 times) by the end of the month.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN): The Research Programs ...
Boston, MA, 04/09/2014 (usastockreport) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announces issue of ordinary shares to carry out its business proceeds.
Related articles »  
What's Hurting These 3 Stocks? � Prana Biotechnology Limited (ADR) (NASDAQ ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) sank 70.49% early Monday after the Australian drug developer said its most advanced potential treatment failed to meet the main goal in a study of patients with Alzheimer's disease.
Related articles »  
Prana Biotechnology Limited (ADR) (PRAN) news: Prana Biotech -13% as ...
Prana is working under a different hypothesis. It, along with a growing number of scientists, now think that small beta-amyloid oligomers are the real culprits in Alzheimer's disease, because they have been found to float into synapses and short ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) Falls On Fears  GSPInsider
Prana Biotechnology (PRAN) Stock Declines; Summer Street Not Impressed with ... (subscription)
Related articles »  
Top Wall Street Stories: FreeSeas Inc (FREE), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) jumped 16.50% after the company said that all resolutions contained in the Notice of Meeting were carried on a show of hands.
Related articles »  
Stocks to Watch : Blucora, Inc. (NASDAQ:BCOR), Petroleo Brasileiro Petrobras ...
Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) monthly performance is -19.41%. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) announced Annual Shareholders Meeting on Nov 12, 2014 at 7:30PM EST.
Prana Biotechnology Limited (ADR) (PRAN) news: Alzheimer's Dementia: Eli ...
Alzheimer's Dementia is a terrible and costly disease and currently the treatments for it are poor. Solanezumab and PBT2 have both shown that they may help the cognitive decline seen in Alzheimer's Dementia.
Why Prana Biotech's & Momenta Pharma's Stock Prices Fell Yesterday
Biotech stocks took a strong hit yesterday, with Prana Biotechnology Limited (ADR) (PRAN) falling over 70% and Momenta Pharmaceuticals, Inc. (MNTA) sliding over 16%.
Motley Fool Australia  The Motley Fool
Prana Biotech Plunges 76%; Drug Fails in Alzheimer Study  Bloomberg
Related articles »  
Why Prana Biotechnology Limited soared 33% today
Biotech company Prana Biotechnology Limited (ASX: PBT) saw its shares soar 33% to 22 cents in trading today, following similar gains (21%) in its NASDAQ-listed shares overnight.
Related articles »